TPTX Annual Shareholders Equity
$954.42 M
-$155.47 M-14.01%
31 December 2021
Summary:
As of January 27, 2025, TPTX annual stockholders equity is $954.42 million, with the most recent change of -$155.47 million (-14.01%) on December 31, 2021. During the last 3 years, it has risen by +$1.00 billion (+2071.71%).TPTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TPTX Quarterly Shareholders Equity
$793.02 M
-$98.33 M-11.03%
30 June 2022
Summary:
As of January 27, 2025, TPTX quarterly stockholders equity is $793.02 million, with the most recent change of -$98.33 million (-11.03%) on June 30, 2022. Over the past year, it has dropped by -$274.49 million (-25.71%).TPTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TPTX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.0% | -25.7% |
| 3 y3 years | +2071.7% | +219.9% |
| 5 y5 years | +3941.7% | - |
TPTX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -14.0% | -28.6% |
Turning Point Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $793.02 M(-11.0%) |
| Mar 2022 | - | $891.35 M(-6.6%) |
| Dec 2021 | $954.42 M(-14.0%) | $954.42 M(-6.2%) |
| Sept 2021 | - | $1.02 B(-4.7%) |
| June 2021 | - | $1.07 B(-3.1%) |
| Mar 2021 | - | $1.10 B(-0.8%) |
| Dec 2020 | $1.11 B | $1.11 B(+58.2%) |
| Sept 2020 | - | $701.59 M(-1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | $710.83 M(+86.2%) |
| Mar 2020 | - | $381.71 M(-5.6%) |
| Dec 2019 | $404.35 M(-935.3%) | $404.35 M(-3.8%) |
| Sept 2019 | - | $420.52 M(+69.6%) |
| June 2019 | - | $247.91 M(-513.2%) |
| Mar 2019 | - | -$60.01 M(+24.0%) |
| Dec 2018 | -$48.41 M(+94.8%) | -$48.41 M |
| Dec 2017 | -$24.84 M | - |
FAQ
- What is Turning Point Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Turning Point Therapeutics?
- What is Turning Point Therapeutics annual shareholders equity year-on-year change?
- What is Turning Point Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Turning Point Therapeutics?
- What is Turning Point Therapeutics quarterly shareholders equity year-on-year change?
What is Turning Point Therapeutics annual stockholders equity?
The current annual shareholders equity of TPTX is $954.42 M
What is the all time high annual shareholders equity for Turning Point Therapeutics?
Turning Point Therapeutics all-time high annual stockholders equity is $1.11 B
What is Turning Point Therapeutics annual shareholders equity year-on-year change?
Over the past year, TPTX annual stockholders equity has changed by -$155.47 M (-14.01%)
What is Turning Point Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of TPTX is $793.02 M
What is the all time high quarterly shareholders equity for Turning Point Therapeutics?
Turning Point Therapeutics all-time high quarterly stockholders equity is $1.11 B
What is Turning Point Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, TPTX quarterly stockholders equity has changed by -$274.49 M (-25.71%)